The FDA recently expanded the approval of the breast cancer drug Kisqali to treat patients with earlier stages of the disease. Thousands of women diagnosed with early-stage breast cancer will have ...
The Food and Drug Administration (FDA) expanded the approval of Jylamvo (methotrexate) to include children with acute lymphoblastic leukemia, marking it as the only oral liquid formulation of ...
Opens in a new tab or window The FDA expanded the approval of the bivalent ... Pfizer announced on Tuesday. The approval expands on the vaccine's existing indications for the prevention of RSV ...
After receiving a green light earlier this year from the FDA, Medtronic has now collected a European approval for the latest version of its transcatheter aortic valve replacement implant.
The FDA expanded the approval of the bivalent ... Pfizer announced on Tuesday. The approval expands on the vaccine's existing ...
with the pediatric approval expected to add another $50 to $100 million. While Jazz's sleep disorder drugs are approved for the same condition as Lumryz, Xywav has the FDA's expanded nod to treat ...
The approval comes just in time for the current ... according to ClinicalTrials.gov. "FDA expands Pfizer’s RSV vaccine label to include all high-risk adults" was originally created and published ...
Following the first approval of generic versions of type 2 diabetes drug, Actos, the FDA has also approved updated prescribing information for Tradjenta tablets, for add-on therapy to insulin ...
The U.S. Food and Drug Administration (FDA) has approved the fourth indication ... the company announced late Friday. With the latest approval, the injectable will be allowed for use in adults ...
Recommendation comes after recent FDA approval and positive CHMP Opinion for ribociclib (Kisqali) to help reduce the risk of recurrence in EBC. (Image Credits: Pexels) The NCCN Clinical Practice ...
If approved, Kisqali could nearly double the number of patients eligible for CDK4/6 inhibitor adjuvant therapy,” said Patrick Horber M.D., president, International, Novartis. “Together with the recent ...